Clinical Trial Update: Effects of Ventavis in Patients With Pulmonary Hypertension (PH) Secondary to Chronic Obstructive Pulmonary Disease (COPD) [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating Ventavis (iloprost) for pulmonary hypertension secondary to chronic obstructive pulmonary disease was terminated, with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Pulmonary Hypertension

Drugs mentioned

• Ventavis (iloprost)

Snippet

Sponsor: Actelion | Conditions: Chronic Obstructive Pulmonary Disease, Pulmonary Hypertension | Phase 2 | Status: TERMINATED | Results posted: 2015-01-06